Omalizumab therapy for chronic spontaneous urticaria: the Israeli experience.
Menachem Rottem, Nancy Agmon‐Levin(Sheba Medical Center), Josef Panasoff(Clalit Health Services), Shmuel Kivity(Tel Aviv Sourasky Medical Center), Shai Cohen, Ramit Maoz‐Segal(Sheba Medical Center), Meir Shalit, Elias Toubi(Bnai Zion Medical Center), Aharon Kessel(Technion – Israel Institute of Technology), Laliv Shamshines, Yael Graif(Rabin Medical Center)
PubMed
August 1, 2014
Cited by 15
Related Papers
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.4k
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k